일반의약품(OTC) 수면보조제 시장 보고서(2026년)
Over-The-Counter (OTC) Sleep Aids Medication Global Market Report 2026
상품코드 : 1957568
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,795,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,822,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,849,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

일반의약품(OTC) 수면보조제 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 226억 9,000만 달러에서 2026년에는 245억 4,000만 달러에 이르고, CAGR 8.1%로 성장할 전망입니다. 지난 몇 년간의 성장은 수면장애 증가, 일반 의약품의 광범위한 가용성, 항히스타민제 기반 수면 보조제에 대한 소비자의 의존도, 소매 약국 네트워크의 확대, 스트레스 및 생활습관 관련 수면 문제 증가에 기인하는 것으로 보입니다.

시판약수면 보조약 시장 규모는 향후 몇 년간 견고성장이 전망됩니다. 2030년에는 331억 5,000만 달러에 이르고, CAGR은 7.8%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 멜라토닌 보충제의 보급 확대, 허브 및 CBD 기반 치료법에 대한 선호도 증가, 전자상거래 및 소비자 직접 판매 확대, 건강 의식 향상 및 셀프 케어 트렌드, 영양소 첨가 및 서방형 제제를 통한 제품 다양화 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 처방전 없이 구입할 수 있는 수면 솔루션에 대한 소비자 선호도 증가, 멜라토닌 및 천연 유래 수면 보조제에 대한 수요 증가, 수면 건강 및 단기 수면 관리에 대한 인식 개선, OTC 수면 보조제의 온라인 판매 채널 확대, 복합 및 다성분 허브 배합을 통한 제품 혁신 등을 들 수 있습니다. 등을 꼽을 수 있습니다.

불면증 유병률 증가는 향후 몇 년 동안 시판되는 수면 보조제 시장의 성장을 견인할 것으로 예측됩니다. 불면증은 잠들기 어려움, 수면 유지의 어려움 또는 이른 아침 각성을 특징으로 하는 수면장애로, 수면의 질 저하와 낮 동안의 기능 장애를 유발합니다. 불면증 유병률 증가는 주로 스트레스 수준 증가에 기인하며, 더 많은 사람들이 업무 관련 압박과 일상적인 문제에 직면하여 휴식과 회복 수면을 방해하고 있습니다. 일반의약품은 처방전 없이도 수면을 촉진하고 수면의 질을 개선함으로써 불면증에 대한 간편하고 편리한 완화책을 제공합니다. 예를 들어, 영국 옥스퍼드 대학 출판부의 2024년 4월 발표에 따르면, 같은 해 북미 성인 여성의 약 19.5%, 성인 남성의 14.0%가 불면증에 시달리고 있으며, 이는 약 1억 2,300만 명에 해당합니다. 따라서 불면증 증가 추세는 일반의약품 수면 보조제 시장의 성장을 가속하고 있습니다.

스트레스와 업무 관련 불안 증가도 향후 몇 년 동안 시판되는 수면 보조제 시장의 성장을 가속할 것으로 예측됩니다. 스트레스와 업무 관련 불안에는 직장의 요구, 경제적 압박, 직무 책임으로 인한 심리적 부담과 지속적인 걱정이 포함되며, 이는 정신 건강과 일상 생활에 부정적인 영향을 미칩니다. 스트레스와 업무 관련 불안 증가는 경제적 불확실성과 금전적 우려로 인해 발생합니다. 특히 팬데믹 이후 직장 환경에서 고용 안정성, 지출, 경제 상황 전반에 대한 우려는 일하는 성인층에게 지속적인 불안감을 불러일으키고 있습니다. 높아진 스트레스와 불안은 처방전 없이 구입할 수 있는 수면제 사용 증가로 직결됩니다. 장기간의 긴장 상태를 경험하는 사람들은 종종 수면장애를 겪게 되고, 불면증을 관리하고 휴식을 개선하기 위해 쉽게 구할 수 있는 수면 보조제를 찾게 되기 때문입니다. 예를 들어, 미국에 본사를 둔 전문 기관인 미국정신의학회(APA)에 따르면, 2024년 5월 기준 전년 대비 불안감이 증가했다고 답한 성인의 비율은 2022년 32%에서 2023년 37%로 증가했으며, 2024년에는 43%로 더 늘어났습니다. 따라서 높아지는 스트레스와 업무 관련 불안감이 일반의약품(OTC) 수면 보조제 시장의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

LSH
영문 목차

영문목차

Over-the-counter (OTC) sleep aids are medications that can be purchased without a prescription to help people fall asleep or enhance sleep quality. They are generally intended for short-term use and function by inducing drowsiness or helping regulate the sleep-wake cycle. These products may cause side effects and are not recommended for managing chronic sleep disorders without medical guidance.

The main types of OTC sleep aid medications include antihistamines, melatonin supplements, herbal supplements, and other categories. Antihistamines are drugs that block the action of histamine in the body to relieve allergy-related symptoms such as sneezing, itching, and a runny nose. They are also used to manage insomnia, provide anxiety relief, and address other conditions that impact sleep quality and duration. Over-the-counter sleep aid medications are distributed through various channels, including online platforms, supermarkets or hypermarkets, pharmacies and drugstores, and specialty health and wellness stores.

Tariffs have influenced the otc sleep aids medication market by increasing costs for imported active ingredients, herbal extracts, and packaging materials used in supplements and formulations. Segments such as melatonin supplements, herbal products, and cbd-based sleep aids are most affected, particularly in regions like Asia-Pacific and North America that rely on global ingredient sourcing. These tariffs have led to pricing pressures and margin adjustments for manufacturers. However, they have also encouraged local sourcing, domestic manufacturing, and formulation innovation to reduce dependency on imports and improve supply chain resilience.

The over-the-counter (otc) sleep aids medication market research report is one of a series of new reports from The Business Research Company that provides over-the-counter (otc) sleep aids medication market statistics, including over-the-counter (otc) sleep aids medication industry global market size, regional shares, competitors with a over-the-counter (otc) sleep aids medication market share, detailed over-the-counter (otc) sleep aids medication market segments, market trends and opportunities, and any further data you may need to thrive in the over-the-counter (otc) sleep aids medication industry. This over-the-counter (otc) sleep aids medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The over-the-counter (otc) sleep aids medication market size has grown strongly in recent years. It will grow from $22.69 billion in 2025 to $24.54 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing prevalence of sleep disturbances, widespread availability of otc medications, consumer reliance on antihistamine-based sleep aids, growth of retail pharmacy networks, rising stress and lifestyle-related sleep issues.

The over-the-counter (otc) sleep aids medication market size is expected to see strong growth in the next few years. It will grow to $33.15 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing adoption of melatonin supplements, increasing preference for herbal and cbd-based remedies, expansion of e-commerce and direct-to-consumer sales, rising health awareness and self-care trends, product diversification with added nutrients and extended-release formulations. Major trends in the forecast period include rising consumer preference for non-prescription sleep solutions, growing demand for melatonin and natural sleep aids, increasing awareness of sleep health and short-term sleep management, expansion of online sales channels for otc sleep aids, product innovation with combination and multi-herb formulations.

The increasing prevalence of insomnia is anticipated to drive the growth of the over-the-counter (OTC) sleep aids medication market in the coming years. Insomnia is a sleep disorder marked by difficulty falling asleep, remaining asleep, or waking too early, leading to poor sleep quality and impaired daytime functioning. The growing prevalence of insomnia is largely attributed to rising stress levels, as more individuals experience work-related pressure and everyday challenges that interfere with relaxation and restorative sleep. Over-the-counter sleep aid medications offer accessible and convenient relief for insomnia by helping people fall asleep more quickly and improve sleep quality without requiring a prescription. For instance, in April 2024, according to Oxford University Press, a UK-based publishing company, approximately 19.5% of adult females and 14.0% of adult males in the Americas were affected by insomnia in 2024, representing nearly 123 million individuals. Therefore, the increasing prevalence of insomnia is fueling the growth of the over-the-counter (OTC) sleep aids medication market.

The rising levels of stress and work-related anxiety are also expected to propel the growth of the over-the-counter (OTC) sleep aids medication market in the coming years. Stress and work-related anxiety involve psychological strain and persistent worry caused by workplace demands, economic pressures, and job-related responsibilities that negatively affect mental health and daily life. The increase in stress and work-related anxiety is driven by economic uncertainty and financial concerns, as worries about job security, expenses, and overall economic conditions create ongoing anxiety among working adults, particularly in post-pandemic work environments. Elevated stress and anxiety directly contribute to greater use of non-prescription sleep medications, as individuals experiencing prolonged tension often develop sleep disturbances and seek readily available sleep aids to manage insomnia and improve rest. For instance, in May 2024, according to the American Psychiatric Association, a US-based professional organization, the proportion of adults reporting higher anxiety than the previous year rose from 32% in 2022 to 37% in 2023 and further increased to 43% in 2024. Therefore, the growing stress and work-related anxiety are driving the growth of the over-the-counter (OTC) sleep aids medication market.

Major companies operating in the over-the-counter (OTC) sleep aids medication market are concentrating on the development of innovative approaches, such as longevity-driven sleep optimization, to deliver personalized and effective solutions that improve sleep quality and support long-term health. Longevity-driven sleep optimization focuses on individualized strategies to enhance sleep patterns and quality in order to promote overall well-being, prevent chronic conditions, and extend healthy lifespan. For example, in November 2024, AgelessRx Inc., a US-based longevity-oriented telehealth platform, introduced a new sleep health program that includes both a prescription sleep aid (Trazodone) and a natural over-the-counter supplement (Tran-Q Sleep). This program is designed to address key dimensions of sleep, including duration, quality, consistency, and timing, marking the company's entry into the sleep health segment with a personalized, research-supported approach that positions sleep as a foundation of long-term health and longevity.

Major companies operating in the over-the-counter (otc) sleep aids medication market are Procter & Gamble Co., Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Perrigo Company plc, Reckitt Benckiser Group plc, Church & Dwight Co. Inc., Prestige Consumer Healthcare Inc., Viatris Inc., Walgreens Boots Alliance Inc., CVS Health Corporation, Rite Aid Corporation, Hyland's Inc., Natrol LLC, Pharmavite LLC (Nature Made), The Bountiful Company, i-Health Inc., Zarbee's Naturals, Olly PBC, Unilever plc, Herbaland Naturals Inc., Garden of Life LLC, Nature's Way Products LLC, Solaray Inc., Nature's Bounty Co., Spring Valley (Walmart Private Label), Equate (Walmart Private Label), GNC Holdings Inc., Blackmores Limited, Himalaya Wellness Company, A.Vogel AG, Schwabe Group

North America was the largest region in the over-the-counter (OTC) sleep aids medication market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the over-the-counter (otc) sleep aids medication market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the over-the-counter (otc) sleep aids medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The over-the-counter (OTC) sleep aids medication market consists of sales of nervous system relaxants, hormonal regulators, sedative antihistamines, anxiolytic herbal remedies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Over-The-Counter (OTC) Sleep Aids Medication Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses over-the-counter (otc) sleep aids medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for over-the-counter (otc) sleep aids medication ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The over-the-counter (otc) sleep aids medication market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Over-The-Counter (OTC) Sleep Aids Medication Market Characteristics

3. Over-The-Counter (OTC) Sleep Aids Medication Market Supply Chain Analysis

4. Global Over-The-Counter (OTC) Sleep Aids Medication Market Trends And Strategies

5. Over-The-Counter (OTC) Sleep Aids Medication Market Analysis Of End Use Industries

6. Over-The-Counter (OTC) Sleep Aids Medication Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Over-The-Counter (OTC) Sleep Aids Medication Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Over-The-Counter (OTC) Sleep Aids Medication Total Addressable Market (TAM) Analysis for the Market

9. Over-The-Counter (OTC) Sleep Aids Medication Market Segmentation

10. Over-The-Counter (OTC) Sleep Aids Medication Market Regional And Country Analysis

11. Asia-Pacific Over-The-Counter (OTC) Sleep Aids Medication Market

12. China Over-The-Counter (OTC) Sleep Aids Medication Market

13. India Over-The-Counter (OTC) Sleep Aids Medication Market

14. Japan Over-The-Counter (OTC) Sleep Aids Medication Market

15. Australia Over-The-Counter (OTC) Sleep Aids Medication Market

16. Indonesia Over-The-Counter (OTC) Sleep Aids Medication Market

17. South Korea Over-The-Counter (OTC) Sleep Aids Medication Market

18. Taiwan Over-The-Counter (OTC) Sleep Aids Medication Market

19. South East Asia Over-The-Counter (OTC) Sleep Aids Medication Market

20. Western Europe Over-The-Counter (OTC) Sleep Aids Medication Market

21. UK Over-The-Counter (OTC) Sleep Aids Medication Market

22. Germany Over-The-Counter (OTC) Sleep Aids Medication Market

23. France Over-The-Counter (OTC) Sleep Aids Medication Market

24. Italy Over-The-Counter (OTC) Sleep Aids Medication Market

25. Spain Over-The-Counter (OTC) Sleep Aids Medication Market

26. Eastern Europe Over-The-Counter (OTC) Sleep Aids Medication Market

27. Russia Over-The-Counter (OTC) Sleep Aids Medication Market

28. North America Over-The-Counter (OTC) Sleep Aids Medication Market

29. USA Over-The-Counter (OTC) Sleep Aids Medication Market

30. Canada Over-The-Counter (OTC) Sleep Aids Medication Market

31. South America Over-The-Counter (OTC) Sleep Aids Medication Market

32. Brazil Over-The-Counter (OTC) Sleep Aids Medication Market

33. Middle East Over-The-Counter (OTC) Sleep Aids Medication Market

34. Africa Over-The-Counter (OTC) Sleep Aids Medication Market

35. Over-The-Counter (OTC) Sleep Aids Medication Market Regulatory and Investment Landscape

36. Over-The-Counter (OTC) Sleep Aids Medication Market Competitive Landscape And Company Profiles

37. Over-The-Counter (OTC) Sleep Aids Medication Market Other Major And Innovative Companies

38. Global Over-The-Counter (OTC) Sleep Aids Medication Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Over-The-Counter (OTC) Sleep Aids Medication Market

40. Over-The-Counter (OTC) Sleep Aids Medication Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기